课题基金 / 基金详情

MT2003-23:NON-MYELOBLATIVE HAPLOIDENTICAL HSCT WITH NK CELL INFUSIONS IN HIGH RI

MT2003-23:NON-MYELOBLATIVE HAPLOIDENTICAL HSCT WITH NK CELL INFUSIONS IN HIGH RI
MT2003-23:高 RI 中 NK 细胞输注的非清髓性半相合 HSCT
批准号:
7605991
负责人:
DANIEL J WEISDORF
金额:
$0.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

DANIEL J WEISDORF的其他基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究是为了评估自然杀伤(NK)细胞输注给接受低强度移植前方案的患者的效果,并从半相合的亲属捐赠者那里移植干细胞。我们的假设是,在这一标准方案中加入NK细胞将减少GVHD的发生率,而不会影响植入或导致超过100天的死亡率。此外,NK细胞输注可能会限制移植后癌症复发的风险。我们还在测试NK细胞输注的安全性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is being done to evaluate the effects of an infusion of natural killer (NK) cells given to patients receiving a reduced intensity pre-transplant regimen and stem cell trnsplant from a haploidentical related donor. Our hypothesis is that the addition of NK cells to this standard regimen will reduce the incidence of GVHD without compromising engraftment or leading to excess day +100 mortality. Additionally, the NK cell infusion may limit the risks of cancer relapse after transplant. We are also testing the safety of the NK cell infusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Off-The-Shelf Dual Targeted NK Cells For NHL
  • 批准号:
    10390387
  • 项目类别:
  • 资助金额:
    $37.17万
  • 财政年份:
    2005
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位:
Clinical Transplantation Exploiting NK Cell Activity
  • 批准号:
    8533762
  • 项目类别:
  • 资助金额:
    $46.12万
  • 财政年份:
    2005
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位:
NON-MYELOBLATIVE HAPLOIDENTICAL HSCT WITH NK CELL INFUSIONS IN HIGH RISK MYELOID
  • 批准号:
    7375910
  • 项目类别:
  • 资助金额:
    $0.48万
  • 财政年份:
    2005
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位:
Clinical Transplantation Exploiting NK Cell Activity
  • 批准号:
    8321400
  • 项目类别:
  • 资助金额:
    $42.14万
  • 财政年份:
    2005
  • 负责人:
    DANIEL J WEISDORF
  • 依托单位: